Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia · Delayed Price · Currency is AUD 2.310
-0.050 (-2.12%)
Jun 3, 2026, 4:10 PM AEST
Clarity Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Clarity Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $7.13. The average 1-year stock price forecast is 208.66% higher than the current stock price, while the lowest is $5.20 (+125.11%) and the highest is $8.41 (+264.07%).
Price Target: $7.13 (+208.66%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for Clarity Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 1 | 3 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 3 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $8.41 | Buy | Maintains | $8.41 | +264.07% | Apr 13, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $6.40 → $6.50 | Buy | Maintains | $6.40 → $6.50 | +181.39% | Apr 1, 2026 |
| Jefferies | Jefferies | Buy Upgrades $5.00 | Buy | Upgrades | $5.00 | +116.45% | Dec 16, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.